Gupta Suneel has filed 18 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 45000 shares of Protagonist Therapeutics, Inc ($PTGX) on November 25, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 25, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Common Stock | 45000 | $7.38 | 229,611.0000 | 61,767,934 | 24.38% | 0.07% |
| Nov. 25, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Common Stock | 45000 | $8.02 | 274,611.0000 | 61,767,934 | 19.60% | 0.07% |
| Nov. 25, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Common Stock | 85000 | $7.80 | 359,611.0000 | 61,767,934 | 30.95% | 0.14% |
| Nov. 25, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | S | Common Stock | 103437 | $46.04 | 256,174.0000 | 61,767,934 | 28.76% | 0.17% |
| Nov. 26, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Common Stock | 30000 | $12.17 | 286,174.0000 | 61,767,934 | 11.71% | 0.05% |
| Nov. 26, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | S | Common Stock | 19191 | $45.50 | 266,983.0000 | 61,767,934 | 6.71% | 0.03% |
| Nov. 26, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Common Stock | 450 | $12.17 | 267,433.0000 | 61,767,934 | 0.17% | 0.00% |
| Nov. 25, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Stock Option (right to buy) | 45000 | $0.00 | 0.0000 | 61,767,934 | 100.00% | 0.07% |
| Nov. 25, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Stock Option (right to buy) | 45000 | $0.00 | 0.0000 | 61,767,934 | 100.00% | 0.07% |
| Nov. 25, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Stock Option (right to buy) | 85000 | $0.00 | 0.0000 | 61,767,934 | 100.00% | 0.14% |
| Nov. 26, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Stock Option (right to buy) | 30000 | $0.00 | 93,750.0000 | 61,767,934 | 24.24% | 0.05% |
| Nov. 26, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Stock Option (right to buy) | 450 | $0.00 | 93,300.0000 | 61,767,934 | 0.48% | 0.00% |
| Feb. 26, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | F | Common Stock | 4282 | $29.53 | 183,285.0000 | 56,763,559 | 2.28% | 0.01% |
| Jan. 9, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Common Stock | 5000 | $7.38 | 192,567.0000 | 56,763,559 | 2.67% | 0.01% |
| Jan. 9, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | S | Common Stock | 5000 | $25.00 | 187,567.0000 | 56,763,559 | 2.60% | 0.01% |
| Jan. 9, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 45,000.0000 | 56,763,559 | 10.00% | 0.01% |
| Jan. 2, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | A | Common Stock | 19250 | $0.00 | 187,567.0000 | 56,763,559 | 11.44% | 0.03% |
| Jan. 2, 2024 | Protagonist Therapeutics, Inc | $PTGX | Gupta Suneel | Chief Development Officer | A | Stock Option (right to buy) | 71500 | $0.00 | 71,500.0000 | 56,763,559 | 9999.99% | 0.13% |